Skip to main content

Jaguar Health, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

JAGX$0.44+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PageNo.
PART I. — FINANCIAL INFORMATION1
Item 1. Condensed Consolidated Financial Statements1
Condensed Consolidated Balance Sheets1
Condensed Consolidated Statements of Operations2
Condensed Consolidated Statements of Comprehensive Losses3
Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Stockholders’ Equity4
Condensed Consolidated Statements of Cash Flows8
Notes to Condensed Consolidated Financial Statements10
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations54
Item 3. Quantitative and Qualitative Disclosures About Market Risk71
Item 4. Controls and Procedures71
PART II. — OTHER INFORMATION72
Item 1. Legal Proceedings72
Item 1A. Risk Factors72
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds73
Item 3. Defaults Upon Senior Securities73
Item 4. Mine Safety Disclosures73
Item 5. Other Information73
Item 6. Exhibits74
SIGNATURE75
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.